Tech Company Inital Public Offerings
Obalon Therapeutics IPO
Headquartered in Carlsbad, Obalon Therapeutics is now a public company.
Transaction Overview
Company Name
Announced On
10/5/2016
Transaction Type
IPO
Amount
$75,000,000
Proceeds Purpose
We currently intend to use the net proceeds we receive from this offering as follows: approximately $33.0 million to $40.0 million for the commercialization of our Obalon balloon system, including $30.0 million to $35.0 million for the development of our sales and marketing infrastructure and $3.0 million to $5.0 million for the expansion of our manufacturing facilities; approximately $13.0 million to $15.0 million for continued research and development efforts; and the remaining for working capital and other general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
5421 Avenida Encinas F
Carlsbad, CA 92008
USA
Carlsbad, CA 92008
USA
Phone
Website
Email Address
Not Recorded
Overview
The Obalon (NASDAQ: OBLN) balloon assists with weight loss by helping you feel full sooner and eat less. This, along with diet and exercise, jump-starts your efforts, proving that when it comes to losing weight, less is truly more.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Andrew Rasdal
Chief Executive Officer
William Plovanic
Chief Technical Officer
Mark Brister
VP - Finance
Nooshin Hussainy
VP - Regulatory Affairs
Amy VandenBerg
Browse more venture capital transactions:
Prev: 10/5/2016: WellFount venture capital transaction
Next: 10/6/2016: Enable Injections venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs